4294 Trm112p-like
Ligands and drugs
Aggregated over all current member domains of this group. Drug annotations come from DrugDomain; buffers and crystallization additives are excluded from the tables below.
Chemical profile
ClassyFire chemical superclasses of the ligands bound by this X-group's proteins, from DrugDomain annotations.
The raw number of superclasses rises with the number of proteins sampled; the per-20 value compares X-groups at equal depth.
| Superclass | Proteins | Expected | 0.25×observed / expected4× | Ratio | Significance |
|---|---|---|---|---|---|
| Homogeneous metal compounds | 15 | 15.5 | 0.97× | q = 1.00 | |
| Homogeneous non-metal compounds | 4 | 6.8 | 0.59× | q = 0.36 | |
| Organic oxygen compounds | 2 | 6.3 | 0.32× | q = 0.11 | |
| Nucleosides, nucleotides, and analogues | 0 | 8.7 | 0 | q = 2.2e-4 | |
| Organoheterocyclic compounds | 10 | 4.9 | 2.06× | not tested | |
| Lipids and lipid-like molecules | 6 | 3.5 | 1.71× | not tested | |
| Benzenoids | 2 | 2.3 | 0.87× | not tested | |
| Organic acids and derivatives | 1 | 4.9 | 0.20× | not tested |
Unit: a protein (UniProt accession) with a ligand-binding domain in this X-group, counted once per superclass. Expected counts use each superclass's frequency across all ligand-binding X-groups; significance is Fisher's exact test with Benjamini–Hochberg correction. Buffers and crystallization additives are excluded. ECOD v295.2; the method follows the ECOD 2027 update, whose published figures used a slightly different artifact filter.
DrugBank compounds
| DrugBank | PDB ligand | Name | Domains |
|---|---|---|---|
| DB03317 | HEC | Ferroheme C | 16 |
| DB01117 | AOQ | Atovaquone | 6 |
| DB01728 | PEF | 1,2-dihexadecanoyl-sn-glycero-3-phosphoethanolamine | 5 |
| DB00126 | ASC | Ascorbic acid | 4 |
| DB07778 | FMX | (S)-famoxadone | 4 |
| DB09270 | U10 | Ubidecarenone | 2 |
| DB18267 | HEM | Ferroheme | 2 |
| DB00172 | PRO | Proline | 1 |
| DB02686 | UMQ | Undecyl-Beta-D-Maltopyranoside | 1 |
| DB07640 | DCQ | 2-decyl-5,6-dimethoxy-3-methylcyclohexa-2,5-diene-1,4-dione | 1 |
Most frequently bound compounds
| PDB ligand | Name | Domains in contact |
|---|---|---|
| FES | FE2/S2 (INORGANIC) CLUSTER | 689 |
| SMA | STIGMATELLIN A | 42 |
| HEC | HEME C | 16 |
| ZNmetal | ZINC ION | 15 |
| MGmetal | MAGNESIUM ION | 9 |
| CL | CHLORIDE ION | 7 |
| AOQ | 2-[trans-4-(4-chlorophenyl)cyclohexyl]-3-hydroxynaphthalene-1,4-dione | 6 |
| COmetal | COBALT (II) ION | 6 |
| PL9 | 2,3-DIMETHYL-5-(3,7,11,15,19,23,27,31,35-NONAMETHYL-2,6,10,14,18,22,26,30,34-HEXATRIACONTANONAENYL-2,5-CYCLOHEXADIENE-1,4-DIONE-2,3-DIMETHYL-5-SOLANESYL-1,4-BENZOQUINONE | 6 |
| ASC | ASCORBIC ACID | 4 |
| HGmetal | MERCURY (II) ION | 4 |
| NImetal | NICKEL (II) ION | 4 |
| UQ5 | 2,3-DIMETHOXY-5-METHYL-6-(3,11,15,19-TETRAMETHYL-EICOSA-2,6,10,14,18-PENTAENYL)-[1,4]BENZOQUINONE | 4 |
| UQ7 | UBIQUINONE-7 | 4 |
| BNT | 2,5-DIBROMO-3-ISOPROPYL-6-METHYLBENZO-1,4-QUINONE | 2 |
| FEmetal | FE (III) ION | 2 |
| HEM | PROTOPORPHYRIN IX CONTAINING FE | 2 |
| PG0 | 2-(2-METHOXYETHOXY)ETHANOL | 2 |
| U10 | UBIQUINONE-10 | 2 |
| 9YF | (2R)-2-(hexadecanoyloxy)-3-{[(S)-hydroxy{[(1R,2R,3R,4R,5R,6S)-2,3,4,5,6-pentahydroxycyclohexyl]oxy}phosphoryl]oxy}propyl (9S)-9-methyloctadecanoate | 1 |